Paul S Shapiro

This inventor holds 11 USPTO granted patents and 8 published patent applications and 2 EPO patents. Top assignees: University System of Maryland, The United States Government as Represented by the Department of Veterans Affairs, Gen1e Lifesciences Inc.. Active years: 2014-2026.

USPTO Granted Patents = 11 (Patent Applications = 8)

% Patents Active = 81.8

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 2.4

ph-index = 4

Forward Citations = 164(Granted Patents)

Location History:

Birmingham, MI (US) (2014)
Bloomfield Hills, MI (US) (2015)
Baltimore, MD (US) (2015 - 2024)

Company Filing History:

9 out of 2,023

University System of Maryland

patents

4 out of 955

The United States Government as Represented by the Department of Veterans Affairs

patents

1 out of 9

Gen1e Lifesciences Inc.

patents

4. 2 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 2014-2026

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12734176 - Non-catalytic substrate-selective p38α-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof (2026-09-15),

2. 12404259 - Inhibitors of extracellular signal-regulated kinase (2025-09-02),

3. 12202810 - Non-ATP/catalytic site p38 mitogen activated protein kinase inhibitors (2025-01-21),

4. 11911393 - Non-catalytic substrate-selective p38alpha-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof (2024-02-27),

5. 11911392 - Non-catalytic substrate-selective p38α-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof (2024-02-27),

6. 11718595 - Non-ATP/catalytic site p38 Mitogen Activated Protein Kinase inhibitors (2023-08-08),

7. 11357781 - Non-catalytic substrate-selective, p38α-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof (2022-06-14),

8. 11078171 - Non-ATP/catalytic site p38 mitogen activated protein kinase inhibitors (2021-08-03),

9. 9198763 - Surgical technique using a contoured allograft cartilage as a spacer of the carpo-metacarpal joint of the thumb or tarso-metatarsal joint of the toe (2015-12-01),

10. 9115122 - Non-ATP dependent inhibitors of extracellular signal-regulated kinase (ERK) (2015-08-25),

11. 8834568 - Surgical technique using a contoured allograft cartilage as a spacer of the carpo-metacarpal joint of the thumb or tarso-metatarsal joint of the toe (2014-09-16),

Title: The Innovative Journey of Paul S Shapiro

Introduction: Paul S Shapiro, a distinguished inventor hailing from Baltimore, MD, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Paul S Shapiro's latest patents include cutting-edge advancements in artificial intelligence, renewable energy technologies, and medical devices, showcasing his versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Paul S Shapiro has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing solutions that push the boundaries of what is possible. His work has not only revolutionized industries but has also improved the lives of countless individuals around the world.

Collaborations: Throughout his career, Paul S Shapiro has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work seamlessly in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion: In conclusion, Paul S Shapiro's passion for innovation, coupled with his relentless drive to make a positive impact on society, sets him apart as a true pioneer in the world of inventions. His continued dedication to pushing the envelope and challenging the status quo ensures that his legacy will endure for years to come.